Learn some of the recommendations from the Handbook of Good Psychiatric Management for Borderline Personality Disorder.  This episode addresses the clinical approach and drug management in the good psychiatric management of BPD. 

Faculty: Paul Links, M.D.  Host: Jessica Diaz, M.D.

• Learn more about our memberships here
• Earn 0.5 CMEs: Pharmacologic Management of BPD: Recent Developments
• Good Psychiatric Management for BPD

How do you distinguish obsessive-compulsive and related disorders from habits? In this episode, we discuss the varying presentations of OCRDs and challenges in their management, including practical recommendations for psychopharmacologic management. 

Guest: Robert Hudak, M.D.  Interviewer: Wegdan Rashad, M.D.  Host: Jessica Diaz, M.D.

• Learn more about our memberships here
• Earn 0.5 CMEs: Obsessive-Compulsive and Related Disorders - Interview with Robert Hudak, M.D.

What other medications can we offer to our patients with BPD? This episode discusses some novel medication approaches used in borderline personality disorder, including omega-3 fatty acids, methylphenidate, clonidine, doxazosin, memantine, and oxytocin. 

Faculty: Paul Links, M.D.  Host: Jessica Diaz, M.D.

• Learn more about our memberships here
• Earn 0.5 CMEs: Pharmacologic Management of BPD: Recent Developments
• Omega-3 Fatty Acids, Methylphenidate, Clonidine, Doxazosin, Memantine, and Oxytocin for BPD

Is lithium really effective in patients with a high risk of suicide? In this episode, Dr. Phelps discusses a randomized clinical trial that assessed the efficacy of adding lithium to an existing medication regimen for reducing the rate of suicide-related events in veterans with bipolar disorder and depression. 

Faculty: Jim Phelps, M.D.  Host: Jessica Diaz, M.D.

• Learn more about our memberships here
• Earn 0.5 CMEs: Quick Take Vol. 36
• Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder

Are mood stabilizers effective for borderline personality disorder? This episode discusses the use of lamotrigine and lithium in BPD patients, including possible benefits, concerns, and recommendations regarding these medications. 

Faculty: Paul Links, M.D.  Host: Jessica Diaz, M.D.

• Learn more about our memberships here
• Earn 0.5 CMEs: Pharmacologic Management of BPD: Recent Developments
• Mood Stabilizers for BPD: Lamotrigine and Lithium

Should we target anxiety disorders and sleep-related problems simultaneously? In this episode, Dr. Phelps discusses a narrative review to provide an overview of the evidence of the associations between anxiety disorders and sleep-related problems in children and adolescents. 

Faculty: Jim Phelps, M.D.  Host: Jessica Diaz, M.D.

• Learn more about our memberships here
• Earn 0.5 CMEs: Quick Take Vol. 36
• Treatment Implications of Sleep‑Related Problems in Pediatric Anxiety Disorders: A Narrative Review of the Literature

This episode discusses the use of antipsychotics in patients with borderline personality disorder, including specific information on quetiapine and clozapine and some tips regarding the use of antipsychotics in these cases.              

Faculty: Paul Links, M.D. Host: Jessica Diaz, M.D.

• Learn more about our memberships here
• Earn 0.5 CMEs: Pharmacologic Management of BPD: Recent Developments
• Antipsychotics for BPD

Which medications can we offer for alcohol use disorder? This episode will offer practical tips for selecting and initiating medications for managing patients with at-risk drinking and alcohol use disorder.

Guest: Joji Suzuki, M.D. Interviewer: Wegdan Rashad, M.D. Host: Jessica Diaz, M.D.

• Learn more about our memberships here
• Earn 0.5 CMEs: What Clinicians Need to KnowAbout Alcohol Use Disorder -Interview with Joji Suzuki, M.D.

This episode discusses the evidence and benefits of topiramate and stimulant replacement therapy for cocaine use disorder. It also addresses the use of these medications when there are comorbidities, such as alcohol use disorder and ADHD. 

Faculty: Andrew Saxon, M.D.  Hosts: Jessica Diaz, M.D.

• Learn more about our memberships here
• Earn 1 CME: Experimental Pharmacotherapies for Stimulant Use Disorder
• Topiramate and Methylphenidate for Cocaine Use Disorder and Its Comorbidities

In this episode, we discuss the problem of pre-existing mood disorders increasing the risk of hospitalization and death among people infected with COVID-19. Why does this occur?

Faculty: Jim Phelps, M.D. Host: Jessica Diaz, M.D.

• Learn more about our memberships here
• Earn 0.5 CMEs: Quick Take Vol. 34
• Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death